`Case 1:14-cv-02758-PAC Document 32 Filed 10/11/14 Page 1 of 3
`
`EXHIBIT A
`
`EXHIBIT A
`
`
`
`Case 1:14-cv-02758-PAC Document 32 Filed 10/11/14 Page 2 of 3
`Case L:l-2 cv 00024 DLC Document 85 Filed 03/25ll-3 Page 1- of 2
`
`UNITED STATES DISTRTCT COURT
`SOUTHERN DISTRICT OF NEW YORK
`
`TAKEDA PHARMACEUTICAL COMPANY I,TD
`eL al, ,
`Pl-aintif f s,
`
`MYLAN, fNC, , et aI
`
`Defendants.
`
`X
`
`X
`
`1,2 Civ. 24 (DLC)
`
`ORDER
`
`ri\ll{]Ài
`
`sf as/ ß
`
`DENISE COTE, DistricL 'Judge:
`On March 22, 2oI3, the defendanLs Mylan Inc. and Mylan
`Pharmaceuticals Inc. ( "MyLan" ) submitted a LeLter regarding t'he
`sequence of experL reports wi th respecL to any secondary
`In Lhe
`consideration of non-obviousness ( "March 22 feLter" ) .
`March 22 letter, Mylan indicates that, depending on the
`fulfil-fment of their discovery obligations, Mylan
`plaintiffs,
`may seek Lo serve a rebuLtal report in accordance with Federal-
`Rul-es of Civil Procedure 26(a) (2) (D) (il) and 26(e). The
`obJ-igation to supplement pur:suant to RuIe 26(e) applies to
`The requirements of Rul-e
`"incompJ-ete or i-ncorrect" dj-sclosures.
`It is
`a courL order.
`26 (a) (2) (D) (f i) apply in the absence of
`
`hereby
`ORDERED that the defendants must serve their compleLe
`serve a supplemental
`expert report on May 24. They may not,
`
`
`
`Case 1:14-cv-02758-PAC Document 32 Filed 10/11/14 Page 3 of 3
`Case I:I2 cv 00024 DLC Document 85 Filed 03/2511-3 Page 2 ol2
`
`report followíng receipt of the ,June 21 rebutLal reporL without
`Ieave of the Court.
`
`SO ORDERED:
`New York, New York
`March 25, 201-3
`
`Dated
`
`rs
`Unit.ed St tes District 'Judge
`
`COTE
`
`D
`
`z
`
`